Axsome Plots New Fibromyalgia Trial After FDA Refuses Review of Former Pfizer Candidate on June 11, 2025 Analgesics AXS-14 Axsome Clinical Trials esreboxetine Fibromyalgia File (record) Pfizer refusal trial design United States Food and Drug Administration +
FDA Postpones Opioids Advisory Committee Meeting and Cancels Kidney Drug Review on January 29, 2025 Advisory Committees Analgesics cancellation kidney drug Opioid regulatory meetings United States Food and Drug Administration +